1. Home
  2. CGO vs RENB Comparison

CGO vs RENB Comparison

Compare CGO & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGO
  • RENB
  • Stock Information
  • Founded
  • CGO 2004
  • RENB 2011
  • Country
  • CGO United States
  • RENB United States
  • Employees
  • CGO N/A
  • RENB N/A
  • Industry
  • CGO Investment Managers
  • RENB Biotechnology: Pharmaceutical Preparations
  • Sector
  • CGO Finance
  • RENB Health Care
  • Exchange
  • CGO Nasdaq
  • RENB Nasdaq
  • Market Cap
  • CGO 105.3M
  • RENB 121.3M
  • IPO Year
  • CGO N/A
  • RENB N/A
  • Fundamental
  • Price
  • CGO $9.82
  • RENB $0.35
  • Analyst Decision
  • CGO
  • RENB
  • Analyst Count
  • CGO 0
  • RENB 0
  • Target Price
  • CGO N/A
  • RENB N/A
  • AVG Volume (30 Days)
  • CGO 34.7K
  • RENB 855.6K
  • Earning Date
  • CGO 01-01-0001
  • RENB 05-14-2025
  • Dividend Yield
  • CGO 9.25%
  • RENB N/A
  • EPS Growth
  • CGO N/A
  • RENB N/A
  • EPS
  • CGO N/A
  • RENB N/A
  • Revenue
  • CGO N/A
  • RENB N/A
  • Revenue This Year
  • CGO N/A
  • RENB N/A
  • Revenue Next Year
  • CGO N/A
  • RENB N/A
  • P/E Ratio
  • CGO N/A
  • RENB N/A
  • Revenue Growth
  • CGO N/A
  • RENB N/A
  • 52 Week Low
  • CGO $7.90
  • RENB $0.32
  • 52 Week High
  • CGO $10.93
  • RENB $2.70
  • Technical
  • Relative Strength Index (RSI)
  • CGO 44.33
  • RENB 29.29
  • Support Level
  • CGO $9.70
  • RENB $0.35
  • Resistance Level
  • CGO $10.20
  • RENB $0.39
  • Average True Range (ATR)
  • CGO 0.40
  • RENB 0.07
  • MACD
  • CGO 0.04
  • RENB -0.00
  • Stochastic Oscillator
  • CGO 64.16
  • RENB 11.00

About CGO Calamos Global Total Return Fund

Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.

About RENB Renovaro Biosciences Inc.

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

Share on Social Networks: